Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: How should we conciliate these new findings with the Zephyr trial results?

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: How should we conciliate these new findings with the Zephyr trial results?'. Together they form a unique fingerprint.